DermTech Announces Three New Scientific Advisory Board Members

LA JOLLA, Calif.–(BUSINESS WIRE)–DermTech, a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the additions of Dr. Klaus Busam, Dr. Joslyn Kirby and Dr. Justin Ko to its Scientific Advisory Board.

The Board provides their expertise and unique perspectives, to support DermTech’s existing innovations, development of new technologies as well as emerging technologies that may impact dermatological diseases. Their combined experience in dermatology, skin cancer, genomics and biotech innovations distinguish them as industry leaders and experts in their respective fields.

Klaus Busam, M.D., is a dual board-certified pathologist specializing in melanoma and other skin cancers holding a wealth of expertise in a variety of inflammatory reactions, including eczema and graft versus host disease. He is also an expert in cutaneous reactions to novel therapeutic agents, both targeted and immunomodulatory. Dr. Busam is currently the director of dermatology and immunohistochemistry at Memorial Sloan Kettering Cancer Center and directs the center’s joint dermatopathology training program with Cornell University. He received his medical degree at the University of Freiburg and completed Harvard Medical School’s dermatopathology fellowship prior to his residency at the Brigham’s and Women’s Hospital and Children’s Hospital at Harvard Medical School.

Justin Ko, M.D., M.B.A., serves as director and chief of medical dermatology for Stanford Health Care (SHC) while also spearheading the dermatology department’s efforts around network development, digital health, quality, safety and performance improvement and value-based care. Dr. Ko also chairs the American Academy of Dermatology’s Task Force Committee on Augmented Intelligence. In his clinical work, he focuses on early cancer detection and translational research. Dr. Ko received his bachelor’s degree from Harvard University and his combined medical and business degree from Tufts University, then completed the Harvard Dermatology Residency Training Program.

Joslyn Kirby, M.D., M.P.H., currently serves as associate professor of dermatology, director of the Dermatology Residency Program and vice chair of education at Pennsylvania State University. In her clinical and research work, she is interested in acneiform conditions including rosacea and hidradenitis suppurativa and is a board member of the Hidradenitis Suppurativa Foundation. She received her medical degree from the University of Virginia and completed her dermatology residency at the University of Pennsylvania. Dr. Kirby also completed her master’s degree in public health sciences and adult education from Pennsylvania State University.

“It is my pleasure to welcome Drs. Kirby, Busam and Ko to our Scientific Advisory Board. They join an esteemed group of minds that are partnered with us in our mission to transform dermatology,” said John Dobak, M.D., chief executive officer of DermTech. “We look forward to working with them to bring non-invasive, precision genomics to the diagnosis and treatment of dermatologic conditions.”

For more information on the DermTech Scientific Advisory Board, please visit: www.dermtech.com/about-us/scientific-advisory-board.

About DermTech:

DermTech is the leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by our non-invasive skin genomics platform. DermTech’s mission is to transform dermatology with our non-invasive skin genomics platform, to democratize access to high quality dermatology care, and to improve the lives of millions. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early detection of skin cancers, and is developing products that assess inflammatory diseases and customize drug treatments. For additional information on DermTech, please visit DermTech’s investor relations site at: www.DermTech.com.

Contacts